Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06453902
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-12
First Post:
2024-05-28
Brief Title:
TGRX-678 Chinese Phase II in Chronic Myelogenous Leukemia CML Patients
Sponsor:
Shenzhen TargetRx Inc
Organization:
Shenzhen TargetRx Inc
Organization Data
Organization:
Shenzhen TargetRx Inc
Class:
INDUSTRY
Study ID:
TGRX-678-2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shenzhen TargetRx Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Peking University Peoples Hospital | OTHER |